Fracture healing in osteoporosis;Frakturheilung bei osteoporose

Osteologie

Volumn 16, Issue 2, 2007, Pages 71-84

  Jakob, F ^a   Seefried, L ^a   Ebert, R ^a   Eulert, J ^a   Wolf, E ^b   Schieker, M ^c   Bocker W ^c   Mutschler, W ^c   Amling, M ^d   Pogoda, P ^d   Schinke, T ^d   Liedert, A ^e   Blakytny, R ^e   Ignatius, A ^e   Claes, L ^e  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY OF ULM   (Germany)

Author keywords

Animal models of osteoporosis; Cloning; Fracture healing; Mechanobiology of fracture healing; Mouse genetics; Osteoporosis; Osteoporotic fracture; Transgenic animal models

Indexed keywords

GROWTH FACTOR; HORMONE;

BIOMECHANICS; BONE DENSITY; BONE MASS; BONE REGENERATION; BONE SCREW; BONE STRENGTH; CALLUS; CELL REGENERATION; CLINICAL PRACTICE; CLONING; COMORBIDITY; CYTOLOGY; ENCHONDRAL OSSIFICATION; FRACTURE HEALING; GENETIC RISK; HEALING; HIGH RISK POPULATION; HUMAN; IMMOBILIZATION; IMPLANT; LIFESTYLE; MEDICAL LITERATURE; MEDICAL RESEARCH; MESENCHYME CELL; MOLECULAR BIOLOGY; MUSCLE; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PEROPERATIVE COMPLICATION; REVIEW; RISK FACTOR; SEX DIFFERENCE; STEM CELL; SURGICAL TECHNIQUE;

EID: 34548639579     PISSN: 10191291     EISSN: None     Source Type: Journal    
DOI: 10.1024/1019-1291.16.2.71     Document Type: Review

References (102)

1. Ferrari SL. Osteoporosis: a complex disorder of aging with multiple genetic and environmental determinants. World Rev Nutr Diet. 2005; 95: 35-51.
2. Painter SE, Kleerekoper M, Camacho PM. Secondary osteoporosis: a review of the recent evidence. Endocr Pract. 2006; 12: 436-445.
3. Ralston SH, de Crombrugghe B. Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev. 2006; 20: 2492-2506.
4. Sambrook P, Cooper C. Osteoporosis. Lancet. 2006; 367(9527): 2010-8.
5. Pfeilschifter J. 2006 DVO-guideline for prevention, diagnosis, and therapy of osteoporosis for women after menopause, for men after age 60 executive summary guidelines. Exp Clin Endocrinol Diabetes. 2006; 114: 611-622.
6. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17: 1726-1733.
7. Seeman E, Eisman JA. 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture. Med J Aust. 2004; 180: 298-303.
8. Wang JW, Li W, Xu SW, Yang DS, Wang Y, Lin M, et al. Osteoporosis influences the middle and late periods of fracture healing in a rat osteoporotic model. Chin J Traumatol. 2005; 8: 111-116.
9. Giannoudis PV, Schneider E. Principles of fixation of osteoporotic fractures. J Bone Joint Surg Br. 2006; 88: 1272-1278.
10. Schmidmaier G, Lucke M, Schwabe P, Raschke M, Haas NP, Wildemann B. Collective review: bioactive implants coated with poly(D,L-lactide) and growth factors IGF-I, TGF-beta1, or BMP-2 for stimulation of fracture healing. J Long Term Eff Med Implants. 2006; 16: 61-69.
11. Augat P, Simon U, Liedert A, Claes L. Mechanics and mechano-biology of fracture healing in normal and osteoporotic bone. Osteoporosis International. 2005; 16: S36-S43.
12. Schutze N, Ebert R, Paunescu K, Jakob F. [Genetics of osteoporosis]. Dtsch Med Wochenschr. 2003; 128: 1609-1614.
13. Engelke K, Gluer CC. Quality and performance measures in bone densitometry: part 1: errors and diagnosis. Osteoporos Int. 2006; 17: 1283-1292.
14. Gluer CC. Quantitative Ultrasound-It is time to focus research efforts. Bone. 2007; 40: 9-13.
15. Gluer CC, Lu Y, Engelke K. Quality and performance measures in bone densitometry. Part 2: fracture risk. Osteoporos Int. 2006; 17: 1449-1458.
16. Gluer MG, Minne HW, Gluer CC, Lazarescu AD, Pfeifer M, Perschel FH, et al. Prospective identification of postmenopausal osteoporotic women at high vertebral fracture risk by radiography, bone densitometry, quantitative ultrasound, and laboratory findings: results from the PIOS study. J Clin Densitom. 2005; 8: 386-395.
17. Fogelman I, Blake GM. Bone densitometry: an update. Lancet. 2005; 366: 2068-2070.
18. Oganov VS. Modern analysis of bone loss mechanisms in microgravity. J Gravit Physiol. 2004; 11: P143-146.
19. Suva LJ, Gaddy D, Perrien DS, Thomas RL, Findlay DM. Regulation of bone mass by mechanical loading: microarchitecture and genetics. Curr Osteoporos Rep. 2005; 3: 46-51.
20. Leblanc AD, Spector ER, Evans HJ, Sibonga JD. Skeletal responses to space flight and the bed rest analog: A review. J Musculoskelet Neuronal Interact. 2007; 7: 33-47.
21. Nuti R, Martini G, Merlotti D, Valleggi F, De Paola V, Gennari L. Professional sport activity and micronutrients: effects on bone mass. J Endocrinol Invest. 2005; 28(Suppl): 52-60.
22. Greene DA, Naughton GA. Adaptive skeletal responses to mechanical loading during adolescence. Sports Med. 2006; 36: 723-732.
23. Priemel M, Munch C, Beil FT, Ritzel H, Amling M. [Pathophysiology and pathomorphology of osteoporosis.]. Radiologe. 2006; 46: 831-838.
24. Blair JM, Zhou H, Seibel MJ, Dunstan CR. Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. Nat Clin Pract Oncol. 2006; 3: 41-49.
25. Jessop HL, Suswillo RF, Rawlinson SC, Zaman G, Lee K, Das-Gupta V, et al. Osteoblast-like cells from estrogen receptor alpha knockout mice have deficient responses to mechanical strain. J Bone Miner Res. 2004; 19: 938-946.
26. Lau KH, Kapur S, Kesavan C, Baylink DJ. Up-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in C57BL/6J osteoblasts as opposed to C3H/HeJ osteoblasts in part contributes to the differential anabolic response to fluid shear. J Biol Chem. 2006; 281: 9576-9588.
27. Lima F, Vico L, Lafage-Proust MH, van der Saag P, Alexandre C, Thomas T. Interactions between estrogen and mechanical strain effects on U2OS human osteosarcoma cells are not influenced by estrogen receptor type. Bone. 2004; 35: 1127-1135.
28. Carter PH, Schipani E. The roles of parathyroid hormone and calcitonin in bone remodeling: prospects for novel therapeutics. Endocr Metab Immune Disord Drug Targets. 2006; 6: 59-76.
29. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001; 22: 477-501.
30. Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006; 92: 4-8.
31. Woitge HW, Scheidt-Nave C, Kissling C, Leidig-Bruckner G, Meyer K, Grauer A, et al. Seasonal variation of biochemical indexes of bone turnover: results of a population-based study. J Clin Endocrinol Metab. 1998; 83: 68-75.
32. Ebert R, Schutze N, Adamski J, Jakob F. Vitamin D signaling is modulated on multiple levels in health and disease. Mol Cell Endocrinol. 2006; 248: 149-159.
33. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006; 116(8): 2062-2072.
34. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006r; 81: 353-373.
35. Cristofalo VJ, Lorenzini A, Allen RG, Torres C, Tresini M. Replicative senescence: a critical review. Mech Ageing Dev. 2004; 125: 827-848.
36. Ebert R, Ulmer M, Zeck S, Meissner-Weigl J, Schneider D, Stopper H, et al. Selenium supplementation restores the antioxidative capacity and prevents cell damage in bone marrow stromal cells in vitro. Stem Cells. 2006; 19.
37. Sethe S, Scutt A, Stolzing A. Aging of mesenchymal stem cells. Ageing Res Rev. 2006; 5: 91-116.
38. Kipling D, Davis T, Ostler EL, Faragher RG. What can progeroid syndromes tell us about human aging? Science. 2004; 305: 1426-1431.
39. Park Y, Gerson SL. DNA repair defects in stem cell function and aging. Annu Rev Med. 2005; 56: 495-508.
40. de Boer J, Andressoo JO, de Wit J, Huijmans J, Beems RB, van Steeg H, et al. Premature aging in mice deficient in DNA repair and transcription. Science. 2002; 296: 1276-1279.
41. Hofer AC, Tran RT, Aziz OZ, Wright W, Novelli G, Shay J, et al. Shared Phenotypes Among Segmental Progeroid Syndromes Suggest Underlying Pathways of Aging. J Gerontol A Biol Sci Med Sci. 2005; 60: 10-20.
42. Scharla SH, Schacht E, Lempert UG. Alfacalcidol versus plain vitamin D in inflammation induced bone loss. J Rheumatol Suppl. 2005; 76: 26-32.
43. Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol. 2006; 12: 4819-4831.
44. Jakob F. [Primary and secondary osteoporosis. The important role of internal medicine in its differential diagnosis]. Internist (Berl). 2005; 46 Suppl 1: S24-30.
45. Ebert R, Jovanovic M, Ulmer M, Schneider D, Meissner-Weigl J, Adamski J, et al. Down-regulation by nuclear factor kappaB of human 25-hydroxyvitamin D3 1alpha-hydroxylase promoter. Mol Endocrinol. 2004; 18: 2440-2450.
46. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA. Fracture healing as a post-natal developmental process: Molecular, spatial, and temporal aspects of its regulation. Journal of Cellular Biochemistry. 2003; 88: 873-884.
47. Phillips AM. Overview of the fracture healing cascade. Injury. 2005; 36 Suppl 3: S5-7.
48. Oreffo RO. Growth factors for skeletal reconstruction and fracture repair. Curr Opin Investig Drugs. 2004; 5: 419-423.
49. Lienau J, Schell H, Epari DR, Schutze N, Jakob F, Duda GN, et al. CYR61 (CCN1) protein expression during fracture healing in an ovine tibial model and its relation to the mechanical fixation stability. J Orthop Res. 2006; 24: 254-262.
50. Mayer H, Bertram H, Lindenmaier W, Korff T, Weber H, Weich H. Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem. 2005; 95: 827-839.
51. Rundle CH, Wang H, Yu H, Chadwick RB, Davis EI, Wergedal JE, et al. Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. Bone. 2006; 38: 521-529.
52. Abdallah BM, Haack-Sorensen M, Fink T, Kassem M. Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged females. Bone. 2006; 39: 181-188.
53. Stenderup K, Justesen J, Eriksen EF, Rattan SI, Kassem M. Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J Bone Miner Res. 2001; 16: 1120-1129.
54. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003; 33: 919-926.
55. Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SI, et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol. 2002; 20: 592-596.
56. Tang YL, Zhao Q, Zhang YC, Cheng L, Liu M, Shi J, et al. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium. Regul Pept. 2004; 117: 3-10.
57. Peng H, Usas A, Olshanski A, Ho AM, Gearhart B, Cooper GM, et al. VEGF Improves, Whereas sFlt1 Inhibits, BMP2-Induced Bone Formation and Bone Healing Through Modulation of Angiogenesis. Journal of Bone and Mineral Research. 2005; 20: 2017-2027.
58. Cornell CN. Internal Fracture Fixation in Patients With Osteoporosis. J Am Acad Orthop Surg. 2003; 11: 109-119.
59. Giannoudis P, Tzioupis C, Almalki T, Buckley R. Fracture healing in osteoporotic fractures: Is it really different?: A basic science perspective. Injury. 2007; 38(1, Supplement): S90-S99.
60. Kim WY, Han CH, Park JI, Kim JY. Failure of intertrochanteric fracture fixation with a dynamic hip screw in relation to pre-operative fracture stability and osteoporosis. Int Orthop. 2001; 25: 360-362.
61. Ito K, Hungerbuhler R, Wahl D, Grass R. Improved intramedullary nail interlocking in osteoporotic bone. J Orthop Trauma. 2001; 15: 192-196.
62. Bakker AD, Klein-Nulend J, Tanck E, Heyligers IC, Albers GH, Lips P, et al. Different responsiveness to mechanical stress of bone cells from osteoporotic versus osteoarthritic donors. Osteoporos Int. 2006; 17: 827-833.
63. Liedert A, Kaspar D, Claes L, Ignatius A. Signal transduction pathways involved in mechanical regulation of HB-GAM expression in osteoblastic cells. Biochem Biophys Res Commun. 2006; 342: 1070-1076.
64. Vogel T, Dobler T, Bitterling H, Biberthaler P, Kanz KG, Pfeifer KJ, et al. [Osteoporosis in traumatology. Prevalence and management]. Unfallchirurg. 2005; 108: 356-364.
65. Namkung-Matthai H, Appleyard R, Jansen J, Hao Lin J, Maastricht S, Swain M, et al. Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone. 2001; 28: 80-86.
66. Lill CA, Hesseln J, Schlegel U, Eckhardt C, Goldhahn J, Schneider E. Biomechanical evaluation of healing in a non-critical defect in a large animal model of osteoporosis. J Orthop Res. 2003; 21: 836-842.
67. Meyer MH, Etienne W, Meyer RA, Jr. Altered mRNA expression of genes related to nerve cell activity in the fracture callus of older rats: A randomized, controlled, microarray study. BMC Musculoskelet Disord. 2004; 5: 24.
68. Meyer RA, Jr., Meyer MH, Tenholder M, Wondracek S, Wasserman R, Garges P. Gene expression in older rats with delayed union of femoral fractures. J Bone Joint Surg Am. 2003; 85-A: 1243-1254.
69. Meyer RA, Meyer MH, Phieffer LS, Banks DM. Delayed union of femoral fractures in older rats:decreased gene expression. BMC Musculoskelet Disord. 2001; 2: 2.
70. Ralph A. Meyer Jr BRDDEHJFSPMHM. Young, adult, and old rats have similar changes in mRNA expression of many skeletal genes after fracture despite delayed healing with age. Journal of Orthopaedic Research. 2006; 24: 1933-1944.
71. Ozawa S, Ogawa T, Iida K, Sukotjo C, Hasegawa H, Nishimura RD, et al. Ovariectomy hinders the early stage of bone-implant integration: histomorphometric, biomechanical, and molecular analyses. Bone. 2002; 30: 137-143.
72. Moroni A, Faldini C, Pegreffi F, Giannini S. HA-coated screws decrease the incidence of fixation failure in osteoporotic trochanteric fractures. Clin Orthop Relat Res. 2004; 425: 87-92.
73. Cook SD, Salkeld SL, Stanley T, Faciane A, Miller SD. Biomechanical study of pedicle screw fixation in severely osteoporotic bone. The Spine Journal. 2004; 4: 402-408.
74. Cornell CN, Lane JM, Poynton AR. Orthopedic management of vertebral and long bone fractures in patients with osteoporosis. Clin Geriatr Med. 2003; 19: 433-455.
75. Cornell CN. Internal fracture fixation in patients with osteoporosis. J Am Acad Orthop Surg. 2003; 11: 109-119.
76. Ali AM, Saleh M, Eastell R, Wigderowitz CA, Rigby AS, Yang L. Influence of bone quality on the strength of internal and external fixation of tibial plateau fractures. J Orthop Res. 2006; 24: 2080-2086.
77. Cole PA, Zlowodzki M, Kregor PJ. Less Invasive Stabilization System (LISS) for fractures of the proximal tibia: indications, surgical technique and preliminary results of the UMC Clinical Trial. Injury. 2003; 34 Suppl 1: A16-29.
78. Drew T, Allcock P. A new method of fixation in osteoporotic bone: A preliminary report. Injury. 2002; 33: 685-689.
79. Ferguson SJ, Winkler F, Nolte LP. Anterior fixation in the osteoporotic spine: cut-out and pullout characteristics of implants. Eur Spine J. 2002; 11: 527-534.
80. Spangler L, Cummings P, Tencer AF, Mueller BA, Mock C. Biomechanical factors and failure of transcervical hip fracture repair. Injury. 2001; 32: 223-228.
81. Pogoda P, Priemel M, Schilling AF, Gebauer M, Catala-Lehnen P, Barvencik F, et al. Mouse models in skeletal physiology and osteoporosis: experiences and data on 14,839 cases from the Hamburg Mouse Archives. J Bone Miner Metab. 2005; 23 Suppl: 97-102.
82. Hishiya A, Watanabe K. Progeroid syndrome as a model for impaired bone formation in senile osteoporosis. J Bone Miner Metab. 2004; 22: 399-403.
83. Gunther T, Schinke T. Mouse genetics have uncovered new paradigms in bone biology. Trends Endocrinol Metab. 2000 Jul; 11: 189-193.
84. Liu YJ, Shen H, Xiao P, Xiong DH, Li LH, Recker RR, et al. Molecular genetic studies of gene identification for osteoporosis: a 2004 update. J Bone Miner Res. 2006; 21: 1511-1535.
85. Egermann M, Goldhahn J, Schneider E. Animal models for fracture treatment in osteoporosis. Osteoporos Int. 2005; 16 Suppl 2: S129-138.
86. Rodgers JB, Monier-Faugere MC, Malluche H. Animal models for the study of bone loss after cessation of ovarian function. Bone. 1993; 14: 369-377.
87. Thorndike EA, Turner AS. In search of an animal model for postmenopausal diseases. Front Biosci. 1998; 3: c17-26.
88. Turner AS. The sheep as a model for osteoporosis in humans. Vet J. 2002; 163: 232-239.
89. Hofmann A, Kessler B, Ewerling S, Weppert M, Vogg B, Ludwig H, et al. Efficient transgenesis in farm animals by lentiviral vectors. EMBO Rep. 2003; 4: 1054-1060.
90. Yang F, Hao R, Kessler B, Brem G, Wolf E, Zakhartchenko V. Rabbit somatic cell cloning: effects of donor cell type, histone acetylation status and chimeric embryo complementation. Reproduction. 2007; 133: 219-230.
91. Kemter E, Philipp U, Klose R, Kuiper H, Boelhauve M, Distl O, et al. Molecular cloning, expression analysis and assignment of the porcine tumor necrosis factor superfamily member 10 gene (TNFSF10) to SSC13q34 - >q36 by fluorescence in situ hybridization and radiation hybrid mapping. Cytogenet Genome Res. 2005; 111: 74-78.
92. Melo EO, Canavessi AM, Franco MM, Rumpf R. Animal transgenesis: state of the art and applications. J Appl Genet. 2007; 48: 47-61.
93. Forsyth JT, Wells DN. Health and neonatal care of bovine clones. Methods Mol Biol. 2006; 348: 91-108.
94. Greiner S, Kadow-Romacker A, Lubberstedt M, Schmidmaier G, Wildemann B. The effect of zoledronic acid incorporated in a poly(D,L-lactide) implant coating on osteoblasts in vitro. J Biomed Mater Res A. 2007; 80: 769-775.
95. Schmidmaier G, Wildemann B, Lubberstedt M, Haas NP, Raschke M. IGF-I and TGF-beta 1 incorporated in a poly(D,L-lactide) implant coating stimulates osteoblast differentiation and collagen-1 production but reduces osteoblast proliferation in cell culture. J Biomed Mater Res B Appl Biomater. 2003; 65: 157-162.
96. Wildemann B, Lubberstedt M, Haas NP, Raschke M, Schmidmaier G. IGF-I and TGF-beta 1 incorporated in a poty(D,L-lactide) implant coating maintain their activity over long-term storage-cell culture studies on primary human osteoblast-like cells. Biomaterials. 2004; 25: 3639-3644.
97. Kim H, Suh H, Jo SA, Kim HW, Lee JM, Kim EH, et al. In vivo bone formation by human marrow stromal cells in biodegradable scaffolds that release dexamethasone and ascorbate-2-phosphate. Biochem Biophys Res Commun. 2005; 332: 1053-1060.
98. Yang X, Tare RS, Partridge KA, Roach HI, Clarke NM, Howdle SM, et al. Induction of human osteoprogenitor chemotaxis, proliferation, differentiation, and bone formation by osteoblast stimulating factor-1/pleiotrophin: osteoconductive biomimetic scaffolds for tissue engineering. J Bone Miner Res. 2003; 18: 47-57.
99. Yang XB, Webb D, Blaker J, Boccaccini AR, Maquet V, Cooper C, et al. Evaluation of human bone marrow stromal cell growth on biodegradable polymer/bioglass composites. Biochem Biophys Res Commun. 2006; 342: 1098-1107.
100. Taguchi Y, Amizuka N, Nakadate M, Ohnishi H, Fujii N, Oda K, et al. A histological evaluation for guided bone regeneration induced by a collagenous membrane. Biomaterials. 2005; 26: 6158-6166.
101. Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther. 2003; 5: 32-45.
102. Tuli R, Nandi S, Li WJ, Tuli S, Huang X, Manner PA, et al. Human mesenchymal progenitor cell-based tissue engineering of a single-unit osteochondral construct. Tissue Eng. 2004; 10: 1169-1179.